SARS

Severe acute respiratory syndrome is a viral respiratory disease of zoonotic origin caused by severe acute respiratory syndrome coronavirus, the first identified strain of the SARS coronavirus species severe acute respiratory syndrome–related coronavirus. The first known cases occurred in November 2002, and the syndrome caused the 2002–2004 SARS outbreak. In the 2010s, Chinese scientists traced the virus through the intermediary of Asian palm civets to cave-dwelling horseshoe bats in Xiyang Yi Ethnic Township, Yunnan. SARS was a relatively rare disease; at the end of the epidemic in June 2003, the incidence was 8,469 cases with a case fatality rate of 11%. No cases of SARS-CoV-1 have been reported worldwide since 2004. In December 2019, another strain of SARS-CoV was identified as severe acute respiratory syndrome coronavirus 2. This new strain causes coronavirus disease 2019, a disease which brought about the COVID-19 pandemic.

Read more in the app

SARS-CoV-2 infects fat tissue, creates inflammatory storm cloud, study finds

Study predicts whether rapid tests will be able to detect future SARS-CoV-2 variants

Team develops method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance

Research Shows All COVID-19 Infections Include a Wide Mix of SARS-CoV-2 Virus Variants

SARS-CoV-2 immunity research: Study suggests breakthrough infection may confer extra protection to vaccinees

Crystal Structure of Key SARS-CoV-2 Enzyme Unraveled – Paving the Way for New COVID Antivirals

SARS-CoV-2 can trigger chronic fatigue syndrome, study finds

SARS-CoV-2 antigen levels linked to patient outcomes

Broadly neutralizing antibody that protects Syrian hamsters against SARS-CoV-2 Omicron variants

Scientists discover antibodies that induce broad immunity against SARS viruses, including emerging variants

The lining of children's noses may provide protection from SARS-CoV-2 infection

Human lung proteins can advance or thwart SARS-CoV-2 infections

Researchers find why bat cells do not get infected by SARS-CoV-2

These Vaccines Will Take Aim at Covid—and Its Entire SARS Lineage

SARS-CoV-2 variants have developed resistance to human interferons, study finds

SARS-CoV-2 hijacks nanotubes between neurons to infect them, study finds

Tunneling nanotubes provide a route for SARS-CoV-2 spreading

Medical face mask membrane that can capture, deactivate SARS-CoV-2 spike protein on contact

Coinfection with influenza A could suppress replication in SARS-CoV-2, study shows

Awash in potential: Wastewater provides early detection of SARS-CoV-2 virus